Effect of omega-3 fatty acid supplementation on platelet aggregability and platelet produced thromboxane. 1987

R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
Kuopio Research Institute of Exercise Medicine, Finland.

We investigated the sustained effect of 12-week supplementation of 2.880 g/day of omega-3 fatty acids on platelet aggregability, platelet produced thromboxane B2 concentration and serum fatty acid composition in a double-blind controlled trial in 44 healthy mildly overweight eastern Finnish men recruited from a representative population sample. The supplementation was discontinued seven days before the biochemical measurements. Body weight, alcohol consumption and dietary composition remained constant during the study. Even though the percentage of eicosapentaenoic acid (20:5 omega 3) in total serum lipids increased by 37% (p less than 0.01) and that of dihomo-gamma-linolenic acid (20:3 omega 6) decreased by 18% (p less than 0.01) more in the omega-3 supplemented than placebo group during supplementation, there were no significant differences in the changes in either the ADP induced platelet aggregation or in vitro platelet produced thromboxane B2 concentration between the groups. These data suggest that omega-3 fatty acids have no detectable sustained effect either on ADP induced platelet aggregation or on thromboxane produced by the platelets in vitro.

UI MeSH Term Description Entries
D008041 Linoleic Acids Eighteen-carbon essential fatty acids that contain two double bonds. Acids, Linoleic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010938 Plant Oils Oils derived from plants or plant products. Oils, Plant,Oils, Vegetable,Plant Oil,Vegetable Oil,Vegetable Oils,Oil, Plant,Oil, Vegetable
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D004042 Dietary Fats, Unsaturated Unsaturated fats or oils used in foods or as a food. Dietary Oils,Unsaturated Dietary Fats,Dietary Fat, Unsaturated,Dietary Oil,Fat, Unsaturated Dietary,Fats, Unsaturated Dietary,Oil, Dietary,Oils, Dietary,Unsaturated Dietary Fat
D004281 Docosahexaenoic Acids C22-unsaturated fatty acids found predominantly in FISH OILS. Docosahexaenoate,Docosahexaenoic Acid,Docosahexenoic Acids,Docosahexaenoic Acid (All-Z Isomer),Docosahexaenoic Acid Dimer (All-Z Isomer),Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt,Docosahexaenoic Acid, Sodium Salt,Acid, Docosahexaenoic,Acids, Docosahexaenoic,Acids, Docosahexenoic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug

Related Publications

R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
January 2001, World review of nutrition and dietetics,
R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
May 2022, Human reproduction (Oxford, England),
R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
May 2007, Pharmacotherapy,
R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
February 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD,
R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
January 2008, Reviews in obstetrics & gynecology,
R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
December 2012, Journal of lipid research,
R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
September 2020, Current nutrition reports,
R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
April 2012, Atherosclerosis,
R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
January 2006, MCN. The American journal of maternal child nursing,
R Salonen, and T Nikkari, and K Seppänen, and J M Venäläinen, and M Ihanainen, and V Rissanen, and R Rauramaa, and J T Salonen
April 2020, The Cochrane database of systematic reviews,
Copied contents to your clipboard!